Ralliant (NYSE:RAL) Sets New 12-Month High – Should You Buy?

Ralliant Corporation (NYSE:RAL) shares hit a new 52-week high during trading on Thursday . The company traded as high as $55.25 and last traded at $54.6750, with a volume of 149005 shares changing hands. The stock had previously closed at $53.83.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Oppenheimer raised their target price on Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research note on Monday, December 15th. Truist Financial initiated coverage on Ralliant in a research report on Friday, December 12th. They set a “buy” rating and a $62.00 target price on the stock. Citigroup raised shares of Ralliant from a “neutral” rating to a “buy” rating and raised their price objective for the company from $53.00 to $61.00 in a research note on Monday, December 8th. Barclays increased their price objective on Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Ralliant in a report on Monday, December 29th. Six investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $58.00.

Ralliant Trading Up 1.6%

The firm has a market capitalization of $6.17 billion and a P/E ratio of 43.05. The stock has a fifty day moving average of $50.49. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.02. The company had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Monday, December 8th were issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Monday, December 8th. Ralliant’s dividend payout ratio (DPR) is presently 15.75%.

Institutional Investors Weigh In On Ralliant

Several hedge funds have recently bought and sold shares of RAL. Dodge & Cox bought a new stake in shares of Ralliant during the 2nd quarter worth $523,571,000. Viking Global Investors LP purchased a new stake in shares of Ralliant during the second quarter worth about $257,200,000. State Street Corp purchased a new position in shares of Ralliant during the second quarter valued at approximately $213,096,000. Flossbach Von Storch SE purchased a new stake in shares of Ralliant in the 2nd quarter worth about $198,077,000. Finally, Norges Bank purchased a new position in shares of Ralliant during the 2nd quarter worth approximately $108,453,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.